REQUEST A DEMO
Total
USD $0.00
Search more companies

Merck Sharp & Dohme (Inter American) Llc. (Ecuador)

Main Activities: Pharmaceutical Preparation Manufacturing | Biological Product (except Diagnostic) Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Merck Sharp & Dohme (Inter American) Llc. Profile Updated: March 18, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Merck Sharp & Dohme (Inter American) Llc. is based in Ecuador, with the head office in Quito. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was established on March 20, 1973. Merck Sharp & Dohme (Inter American) Llc. currently employs 61 (2024) people. From the latest financial highlights, Merck Sharp & Dohme (Inter American) Llc. reported a net sales revenue increase of 18.72% in 2024. During that time, Merck Sharp & Dohme (Inter American) Llc.’s total assets grew by 21.66%.

Headquarters
Av. Naciones Unidas E10-44 Av. Republica Del Salvador Citiplaza El Batan 6
Quito; Pichincha;

Contact Details: Purchase the Merck Sharp & Dohme (Inter American) Llc. report to view the information.

Basic Information
Total Employees:
Purchase the Merck Sharp & Dohme (Inter American) Llc. report to view the information.
Registered Capital:
Purchase the Merck Sharp & Dohme (Inter American) Llc. report to view the information.
Financial Auditors:
Purchase the Merck Sharp & Dohme (Inter American) Llc. report to view the information.
Incorporation Date:
March 20, 1973
Key Executives
Purchase this report to view the information.
Proxy
Company Performance
Financial values in the chart are available after Merck Sharp & Dohme (Inter American) Llc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
18.72%
Total Operating Revenue
18.19%
Operating Profit
349.36%
EBITDA
294.8%
Net Profit/Loss for the Period
N/A
Total Assets
21.66%
Total Equity
5.05%
Operating Profit Margin
2.83%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?